Pro-inflammatory IL-6, a biomarker of obesity and T2D [14, 20, 21] is a critical contributor to insulin resistance [22–24], and cardiovascular disease, including myocardial infarction and atherosclerosis [14, 25, 26]. This evidence concerns the gene IL6 and obesity disorder.